×
Natera Common Stock Net 2014-2025 | NTRA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Natera common stock net for the quarter ending March 31, 2025 was
$0.000B
, a
16.67% increase
year-over-year.
Natera common stock net for 2024 was
$0B
, a
9.09% increase
from 2023.
Natera common stock net for 2023 was
$0B
, a
0% decline
from 2022.
Natera common stock net for 2022 was
$0B
, a
10% increase
from 2021.
View More
Natera Common Stock Net 2014-2025 | NTRA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Natera common stock net for 2024 was
$0B
, a
9.09% increase
from 2023.
Natera common stock net for 2023 was
$0B
, a
0% decline
from 2022.
Natera common stock net for 2022 was
$0B
, a
10% increase
from 2021.
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$151B
CVS Health (CVS)
$87B
Elevance Health (ELV)
$69.7B
Cencora (COR)
$56.8B
DiDi Global (DIDIY)
$25.8B
Labcorp Holdings (LH)
$22.5B
BioMerieux (BMXMF)
$17.2B
EUROFINS SCIENT (ERFSF)
$15.6B
ICON (ICLR)
$14.2B
CochLear (CHEOY)
$13.4B
Medpace Holdings (MEDP)
$12.9B
Solventum (SOLV)
$12.4B
Viatris (VTRS)
$12.4B
Revvity (RVTY)
$10.5B
Caris Life Sciences,�Inc (CAI)
$10.3B
Sonic Healthcare (SKHHY)
$9.1B
Avantor (AVTR)
$8.8B
HealthEquity (HQY)
$7.8B
Charles River Laboratories (CRL)
$7.7B
Bausch + Lomb (BLCO)
$5.2B
Sotera Health (SHC)
$4.5B
BrightSpring Health Services (BTSG)
$4B
Amplifon S.p.A (AMFPF)
$3.9B
GeneDx Holdings (WGS)
$3.6B
Alignment Healthcare (ALHC)
$3B
Concentras Parent (CON)
$3B
Surgery Partners (SGRY)
$2.9B
Organon (OGN)
$2.5B
Premier (PINC)
$2.1B
Progyny (PGNY)
$2B